The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Lysophospholipids activate ovarian and breast cancer cells
Open accessAbstract
We have investigated the effects of phospholipids on activation and proliferation of ovarian and breast cancer cells. Lysophosphatidic acid (LPA), lysophosphatidylserine (LPS) and sphingosylphosphorylcholine (SPC) all induce transient increases in cytosolic free Ca2+ ([Ca2+]i) in both ovarian and breast cancer cell lines. The ability of LPA, LPS and SPC to induce increases in [Ca2+]i in ovarian and breast cancer cells is likely to be due to an interaction with cell-surface receptors as the increases in [Ca2+]i were: (1) due to release of calcium from intracellular stores and not from transmembrane uptake due to changes in permeability; (2) blocked by lanthanum and suramin which do not enter cells; (3) blocked by phorbol esters which interrupt increases in [Ca2+]i induced through a number of different receptors; and (4) not detected in freshly isolated peripheral blood mononuclear cells, indicating cell type specificity. In addition, increases in [Ca2+]i induced by LPA, LPS and SPC in ovarian and breast cancer cells completely self-desensitized and cross-desensitized each other, but did not block increases in [Ca2+]i induced by thrombin. Lysophosphatidylglycerol (LPG), but not other lysophospholipids, inhibited LPA- but not LPS- or SPC-induced increases in [Ca2+]i, suggesting that LPA may interact with a different receptor(s) to LPS or SPC and that their downstream signalling pathways converge or interact. LPA, SPC and LPS also induced rapid increases in tyrosine phosphorylation of specific cellular proteins, including p125FAK. Strikingly, LPA, but not LPS or SPC, induced activation of mitogen-activated protein (MAP) kinases. Despite an ability to activate similar intracellular signaling events, LPA, LPS and SPC exhibited markedly different effects on cell proliferation. Whereas LPA induced a significant increase in cell proliferation, LPS did not substantially alter cell proliferation and SPC inhibited cell proliferation. Surprisingly, phosphatidic acid (PA), which did not induce increases in [Ca2+]i, p125FAK activation or activation of MAP kinases, did induce proliferation of ovarian cancer cells, albeit at higher concentrations that LPA. The discordance between sensitivity to LPG, early biochemical events stimulated, and the eventual proliferation response combine to suggest that LPA probably utilizes a different receptor from LPS, SPC and PA. Therefore ovarian and breast cancer cells are sensitive to the effects of a number of different phospholipids which may play a role in the growth of these tumour cells in the cancer patient and are thus potential targets for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Inositol trisphosphate and calcium signalling
Berridge, M. J. (1993) · Nature · doi:10.1038/361315a0 · Cited by 6,545
A novel multigene family may encode odorant receptors: A molecular basis for odor recognition
Buck, L., & Axel, R. (1991) · Cell · doi:10.1016/0092-8674(91)90418-x · Cited by 4,987
Needleman, P., Truk, J., Jakschik, B. A., Morrison, A. R., & Lefkowith, J. B. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.000441 · Cited by 1,807
Boring, C. C., Squires, T. S., Tong, T., & Montgomery, S. (1994) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.44.1.7 · Cited by 1,315
Anderson, N. G., Maller, J. L., Tonks, N. K., & Sturgill, T. W. (1990) · Nature · doi:10.1038/343651a0 · Cited by 1,063
Inositol Trisphosphate and Calcium Signaling
BERRIDGE, M. J. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb26646.x · Cited by 1,031
van Corven, E. J., Groenink, A., Jalink, K., Eichholtz, T., & Moolenaar, W. H. (1989) · Cell · doi:10.1016/0092-8674(89)90868-4 · Cited by 836
PLATELET ACTIVATING FACTOR: A BIOLOGICALLY ACTIVE PHOSPHOGLYCERIDE
Hanahan, D. J. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.002411 · Cited by 774
Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung
Honda, Z.-I., Nakamura, M., Miki, I., Minami, M., Watanabe, T., Seyama, Y., Okado, H., Toh, H., Ito, K., Miyamoto, T., et al. (1991) · Nature · doi:10.1038/349342a0 · Cited by 586
LISCOVITCH, M. (1994) · Cell · doi:10.1016/0092-8674(94)90148-1 · Cited by 356
Comparative properties of five human ovarian adenocarcinoma cell lines.
Buick, R. N., Pullano, R., & Trent, J. M. (1985) · PubMed · Cited by 349
van Corven, E. J., van Rijswijk, A., Jalink, K., van der Bend, R. L., BLITTERSWIJK, W. J. V., & Moolenaar, W. H. (1992) · Biochemical Journal · doi:10.1042/bj2810163 · Cited by 262
Seufferlein, T., & Rozengurt, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37114-4 · Cited by 256
Hordijk, P. L., Verlaan, I., van Corven, E. J., & Moolenaar, W. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42398-2 · Cited by 237
van der Bend, R. L., Brunner, J., Jalink, K., van Corven, E. J., Moolenaar, W. H., & van Blitterswijk, W. J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05314.x · Cited by 201
Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator
Jalink, K., Hordijk, P. L., & Moolenaar, W. H. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90013-2 · Cited by 159
Transmembrane Receptors and Intracellular Pathways that Control Cell Proliferation
Pouysségur, J., & Seuwen, K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.001211 · Cited by 154
LPA: a novel lipid mediator with diverse biological actions
Moolenaar, W. H. (1994) · Trends in Cell Biology · doi:10.1016/0962-8924(94)90144-9 · Cited by 153
Bacus, S. S., Stancovski, I., Huberman, E., Chin, D., Hurwitz, E., Mills, G. B., Ullrich, A., Sela, M., & Yarden, Y. (1992) · PubMed · Cited by 101
Self-citationCasillas, A. M., Amaral, K. C., Chegini-Farahani, S., & Nel, A. E. (1993) · Biochemical Journal · doi:10.1042/bj2900545 · Cited by 58
Iismaa, T. P., & Shine, J. (1992) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(92)90033-9 · Cited by 39
Lenzen, S., Görlich, J.-K., & Rustenbeck, I. (1989) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(89)90184-3 · Cited by 27
Signalling mechanism in the lysophosphatidylserine-induced activation of mouse mast cells
Bellini, F., Viola, G., Menegus, A. M., Toffano, G., & Bruni, A. (1990) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(90)90079-s · Cited by 21
Platelet-Activating Factor and Related Lipid Mediators 2
(1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-0179-8 · Cited by 12
Cited by
The emerging role of lysophosphatidic acid in cancer
Mills, G. B., & Moolenaar, W. H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1143 · Cited by 1,094
Self-citationLPA Receptors: Subtypes and Biological Actions
Choi, J. W., Herr, D. R., Noguchi, K., Yung, Y. C., Lee, C.-W., Mutoh, T., Lin, M.-E., Teo, S. T., Park, K. E., Mosley, A. N., et al. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105753 · Cited by 839
Lysophospholipid Receptors: Signaling and Biology
Ishii, I., Fukushima, N., Ye, X., & Chun, J. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073731 · Cited by 771
LPA receptor signaling: pharmacology, physiology, and pathophysiology
Yung, Y. C., Stoddard, N. C., & Chun, J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046458 · Cited by 710
Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers
Xu, Y. (1998) · JAMA · doi:10.1001/jama.280.8.719 · Cited by 637
Self-citation
Metadata
- Authors
- Xu, Y., Fang, X. J., Casey, G., & Mills, G. B.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1995-08-01
- Volume
- 309
- Issue
- 3
- Pages
- 933-940
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1794030813
- Cited by
- 282
- References
- 25
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.